Conventional 2D methods have low sampling rate, which results in a lower diagnosis accuracy. By using 3D imaging, JelloX’s technology not only increases the tissue sampling rate, but also solves the problem of tumor heterogeneity by viewing t
During the accelerator, we have found our potential champion/advisor for our company. We are also in the process of setting up a pilot project with two of the pathologists.
"It was a great experience for me to learn more about the business side of the industry, most importantly, I grew a lot as a person in this short period of time as well."
Louis Chen
Business Development, JelloX